Financials data is unavailable for this security.
View more
Year on year TRxADE Health Inc 's revenues fell -19.30% from 10.25m to 8.27m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 3.47m to a larger loss of 17.84m.
Gross margin | -12.30% |
---|---|
Net profit margin | -454.84% |
Operating margin | -432.49% |
Return on assets | -216.70% |
---|---|
Return on equity | -384.06% |
Return on investment | -352.55% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at TRxADE Health Inc fell by 942.98k. Cash Flow from Financing totalled 1.41m or 17.00% of revenues. In addition the company used 2.07m for operations while cash used for investing totalled 275.72k.
Cash flow per share | -17.46 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 8.38 |
---|---|
Tangible book value per share | 8.38 |
More ▼
Balance sheet in USDView more
Current ratio | 4.18 |
---|---|
Quick ratio | 4.18 |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼